Efficacy of antivirals against SARS-CoV-2 main protease and the RNA-dependent RNA polymerase

A tétel rövid nézete
dc.contributor.advisorMahdi, Mohamed
dc.contributor.advisordeptDepartment of Biochemistry and Molecular Biologyhu_HU
dc.contributor.authorAlsheikh, Raghad
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentKiss, Andrea
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Orvosi Vegytani Intézethu_HU
dc.date.accessioned2022-05-31T13:14:18Z
dc.date.available2022-05-31T13:14:18Z
dc.date.created2022-04-27
dc.description.abstractThe World Health Organization (WHO) on the 11th of March 2020 has declared SARS-CoV-2 a pandemic owing to its vast magnitude of global spread. Our research on SARS-CoV-2 is focused on investigation of the FDA approved antivirals against the enzymes participating in the viral life cycle, as viral proteases and the RdRp.hu_HU
dc.description.coursemolekuláris biológiahu_HU
dc.description.courselangangolhu_HU
dc.description.coursespecBiokémia-genomikahu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent31hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/334068
dc.language.isoenhu_HU
dc.subjectSARS-CoV-2hu_HU
dc.subjectMpro
dc.subjectRNA-dependent RNA polymerase
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleEfficacy of antivirals against SARS-CoV-2 main protease and the RNA-dependent RNA polymerasehu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)